Valuation CSPC Pharmaceutical Group Limited

Stocks

Delayed Hong Kong S.E. Other stock markets 07:19:44 10/07/2026 BST			5-day change	1st Jan Change
8.160 ^HKD	+4.08%		+2.00%	-3.20%

06-18	CSPC Pharma's Tumor Drug Gets Trial Nod from US FDA	MT
06-18	CSPC Pharma Unit's Marketing Application for Anti-Inflammatory Drug Accepted in China	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	89,635	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	-7%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	78,772	76,196	73,133
Change	-	-3.79%	-16.18%	-35.07%	84.76%	-9.15%	-3.27%	-4.02%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	10.8x	12.7x	11.6x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.09x	1.92x	1.73x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.9x	1.25x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.51x	2.55x	2.38x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.21x	2.17x	1.94x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.01x	7.7x	6.91x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	8.64x	9.95x	8.98x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	9.58x	10.9x	7.64x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	10.4%	9.21%	13.1%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3652	0.3689	0.385
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.66%	4.7%	4.91%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.723	0.6187	0.6761
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	50.5%	59.6%	56.9%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	35,662	35,144	37,653
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	13,116	9,892	10,578
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,116	7,661	8,140
Net income ¹	6,901	6,949	6,382	4,632	4,409	7,955	6,924	7,556
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,863	-13,439	-16,502
Reference price ²	8.470	8.200	7.260	4.780	8.430	7.840	7.840	7.840
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	22/03/22	22/03/23	20/03/24	28/03/25	25/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	10.84x	2.21x	6.01x	4.66%	11.44B
ELI LILLY AND COMPANY	35.49x	12.92x	26.31x	0.56%	1,085B
JOHNSON & JOHNSON	27.65x	6.35x	17.24x	2.06%	624B
ABBVIE INC.	30.17x	7.39x	15.12x	2.74%	442B
ROCHE HOLDING AG	17.88x	4.44x	10.99x	2.98%	332B
ASTRAZENECA PLC	22.38x	4.7x	13.12x	1.86%	277B
NOVARTIS AG	21.53x	5.52x	13.36x	2.86%	282B
NOVO NORDISK A/S	14.08x	5.27x	10.83x	3.55%	217B
AMGEN INC.	23.79x	6.31x	11.13x	2.77%	196B
GILEAD SCIENCES, INC.	-47.8x	5.8x	32.25x	2.41%	167B
Average	15.60x	6.09x	15.64x	2.65%	363.34B
Weighted average by Cap.	23.98x	7.97x	18.45x	1.98%